Patel Yagnesh sold $1.0M of CBRS

Patel Yagnesh (Chief Accounting Officer) sold 6,079 shares of Cerebras Systems Inc. (CBRS) at an average of $171.53 ($162.45–$189.36, $1.04M total) across 29 trades on 2026-06-25.

Original reporting
SEC EDGAR · Patel Yagnesh
Published Jun 29, 2026, 8:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 29, 2026, 8:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBRS
Neutral
medium confidence
Mentioned
$CBRS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size (~$1.04M) by the Chief Accounting Officer, with holdings after the transaction reported as 4,000 shares.

02

Market read

Traders may monitor for follow-on insider activity, but this disclosure alone does not provide new operating or financial guidance.

03

What to watch

No 10b5-1 plan is noted, but the article provides no context on prior grants, tax events, or whether future sales are planned; without that, signal strength is weak.

Relevance 6/10Novelty 5/10Timing: Form 4 filed 2026-06-29 (covers sales dated 2026-06-25).

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Cerebras Systems (CBRS).

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Cerebras Systems insider (Chief Accounting Officer) sold ~$1.04M of CBRS shares via open-market transactions on 2026-06-25.

Expected impact

Likely limited near-term impact; any effect should fade unless followed by additional disclosures or company-specific news.

Evidence & confidence

The filing is a Form 4 open-market sale with no 10b5-1 plan and a remaining holding of 4,000 shares, but it does not include earnings, guidance, or operational changes.

Market effects

Minimal; insider selling at a single company typically does not reset sector expectations.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification/tax/compensation liquidity rather than a bearish view, especially given multiple trades across a range of prices.

Key entities

  • Cerebras Systems Inc.

    Subject of the Form 4 insider transaction; ticker CBRS.

  • Patel Yagnesh

    Chief Accounting Officer who sold 6,079 shares across 29 trades on 2026-06-25.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Why Cerebras Systems Stock Is Plummeting Today

Cerebras Systems (CBRS) shares fell 9.2% after UBS cut its price target by 24% to $250, citing tempered expectations. Despite the reduction, UBS maintains a buy rating, noting potential upside from OpenAI demand and AWS adoption. The stock has also faced criticism from Culper Research, which took a short position. Cerebras is set to report Q3 earnings on Nov. 12.

$CBRSMed

Why is Cerebras Systems stock sliding today?

Cerebras Systems (CBRS) stock fell 8.3% to a 52-week low of $98.50 after UBS cut its price target to $250 from $330, citing reduced near-term conviction. The decline follows a short-seller report alleging chip degradation and upcoming share unlocks. The stock is down 70% from its high, but analysts maintain Buy ratings.

$CBRSHigh

Cerebras Stock Falls as Short Seller Questions Chip Lifespan

Cerebras Systems (CBRS) fell 5.77% after short seller Culper Research alleged its AI chips have a lifespan of 1.5 to 2.5 years and questioned its technology claims. Cerebras has not responded. The drop follows a lockup expiration and reverses part of a previous rally. The stock is far below its 52-week high of $386.34.

$CBRSHigh

Cerebras Gains 10% on Oracle Cloud Deal as “AI Inference Demands Choice”

Cerebras Systems (CBRS) shares rose 10% and Oracle (ORCL) gained 4% on Oct. 27 after Oracle announced plans to offer Cerebras' AI inference on its cloud starting in 2027. The deal aims to provide customers with more AI chip options. Analysts estimate Cerebras' 2027 revenue at $2.95 billion, though no deal value was disclosed. Cerebras trades at roughly half its average forward price/sales multiple since its IPO.

$CBRSMed

Why Cerebras Systems Stock Jumped on Tuesday

Cerebras Systems (CBRS) stock rose 10.1% after announcing a partnership with Oracle (ORCL) to offer its AI chip technology to Oracle Cloud Infrastructure customers. The company's Wafer-Scale Engine (WSE) is promoted for its large size and reduced latency. Cerebras reported a 287% year-over-year increase in cloud revenue to $128 million in Q2, but continues to incur losses.